SCHEMBL7306151

SCHEMBL7306151

CC(C)[C@H](NC(=O)N(C)Cc1ccccn1)C(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)OC(C)(C)C

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.83
BACE1 P56817 10/20 0.52
MEN1 O00255 1/20 0.52
SLC22A2 O15244 1/20 0.52
SLC22A1 O15245 1/20 0.52
ABCC3 O15438 1/20 0.52
ABCC4 O15439 1/20 0.52
MLNR O43193 1/20 0.52
NR1I2 O75469 1/20 0.52
SLCO2B1 O94956 1/20 0.52
ABCB11 O95342 1/20 0.52
ALDH1A1 P00352 1/20 0.52
PGR P06401 1/20 0.52
ABCB1 P08183 1/20 0.52
CYP3A4 P08684 1/20 0.52
HTR1A P08908 1/20 0.52
ADRA2A P08913 1/20 0.52
ADORA3 P0DMS8 1/20 0.52
CYP2D6 P10635 1/20 0.52
MAPT P10636 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7332468 0.97 CA2 (0.83) CA2BACE1MEN1SLC22A2SLC22A1
SCHEMBL7308930 0.91 CA2 (1.00) CA2BACE1MEN1SLC22A2SLC22A1
SCHEMBL7306173 0.91 CA2 (1.00) CA2BACE1MEN1SLC22A2SLC22A1
SCHEMBL7331805 0.90 CA2 (0.83) CA2BACE1CYP3A4CYP2D6CYP2C19
SCHEMBL7340722 0.90 CA2 (0.83) CA2BACE1CYP3A4CYP2D6CYP2C19
SCHEMBL7332653 0.90 CA2 (0.83) CA2BACE1CYP3A4CYP2D6CYP2C19
SCHEMBL8673387 0.86 CA2 (0.61) CA2BACE1PSEN1PSEN2APH1B
SCHEMBL7299343 0.86 CA2 (0.77) CA2MEN1SLC22A2SLC22A1ABCC3
SCHEMBL7313856 0.86 CA2 (0.77) CA2MEN1SLC22A2SLC22A1ABCC3
SCHEMBL7311939 0.86 CA2 (0.61) CA2BACE1MEN1SLC22A2SLC22A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0486948-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 2000-10-04 EP disclosed
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed